Jan 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Constellation Brands, Merck and WD-40 on Monday.
HIGHLIGHTS
* Constellation Brands Inc STZ.N: JP Morgan cuts to neutral from overweight |
* Intellia Therapeutics Inc NTLA.O: Jefferies cuts target price to $86 from $128 |
* Merck & Co Inc MRK.N: Leerink Partners cuts target price to $119 from $136 |
* Ultragenyx Pharmaceutical Inc RARE.O: Piper Sandler raises target to $140 from $135 |
* WD-40 Co WDFC.O: Jefferies cuts target price to $270 from $280 |
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* Advanced Micro Devices AMD.O: TD Cowen cuts target price to $150 from $185 |
* Constellation Brands Inc STZ.N: JP Morgan cuts target price to $203 from $262 |
* Constellation Brands Inc STZ.N: JP Morgan cuts to neutral from overweight |
* Douglas Emmett Inc DEI.N: Piper Sandler raises to overweight from neutral |
* Exelixis Inc EXEL.O: Piper Sandler raises target price to $37 from $36 |
* IGM Biosciences Inc IGMS.O: JP Morgan raises to neutral from underweight |
* Intellia Therapeutics Inc NTLA.O: Jefferies cuts target price to $86 from $128 |
* Intellia Therapeutics Inc NTLA.O: Oppenheimer cuts target price to $40 from $60 |
* Legalzoom.com Inc LZ.O: JP Morgan raises target price to $9 from $8 |
* Legalzoom.com Inc LZ.O: JP Morgan raises to overweight from underweight |
* Merck & Co Inc MRK.N: Leerink Partners cuts target price to $119 from $136 |
* Neogenomics Inc NEO.O: BTIG cuts target price to $18 from $21 |
* Quanterix Corp QTRX.O: TD Cowen cuts target price to $11 from $15 |
* Ultragenyx Pharmaceutical Inc RARE.O: Piper Sandler raises target to $140 from $135 |
* Verona pharma Plc VRNA.O: Jefferies raises target price to $70 from $50 |
* Walgreens WBA.O: TD Cowen raises target price to $15 from $14 |
* WD-40 Co WDFC.O: Jefferies cuts target price to $270 from $280 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。